Zephyr AI: Bringing AI and machine learning to new tools in health care

Editor’s note: At the start of the year, we look at which young companies have caught our eye for hitting a milestone, bringing in funding or growing its revenue base. This company has made our list of our Startups to Watch for 2023. See them all here.

Want proof that machine learning and artificial intelligence are still hot commodities in the venture capital market? Take a look at the $18.5 million seed round last March — yes, seed — for Zephyr AI.

The McLean company was founded in 2021 by investment and incubation firm Red Cell Partners, with Yisroel Brumer as CEO, Jeff Sherman as chief technology officer and Grant Verstandig as executive chairman. Last year, David Morgan filled in the CEO role, with Brumer acting as executive vice chairman. They built Zephyr AI to use medical data, like clinical research or hospital patient data, to develop tools and insights for medical providers to improve outcomes in patient care and research.

This breaks down into two products now under…

Read the full story from the Washington Business Journal.
Federal News Network Logo
Log in to your WTOP account for notifications and alerts customized for you.

Sign up